SB Investment Advisers (UK)’s Guardant Health GH Stock Holding History

SB Investment Advisers (UK)’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-503,592	Closed	-$33.4M	–	15
2022 Q1	$33.4M	Hold	503,592	–	–	0.16%	14
2021 Q4	$50.4M	Sell	503,592 -100,351	-17%	-$10.4M	0.15%	14
2021 Q3	$75.5M	Hold	603,943	–	–	0.23%	10
2021 Q2	$75M	Sell	603,943 -5,576,587	-90%	-$750M	0.15%	12
2021 Q1	$943M	Sell	6,180,530 -157,430	-2%	-$23.8M	1.63%	8
2020 Q4	$817M	Sell	6,337,960 -7,700,000	-55%	-$886M	3.29%	5
2020 Q3	$1.57B	Hold	14,037,960	–	–	13.48%	2
2020 Q2	$1.14B	Sell	14,037,960 -8,912,500	-39%	-$718M	12.41%	2
2020 Q1	$1.6B	Hold	22,950,460	–	–	17.21%	2
2019 Q4	$1.79B	Hold	22,950,460	–	–	19.66%	2
2019 Q3	$1.46B	Sell	22,950,460 -4,900,000	-18%	-$432M	16.93%	2
2019 Q2	$2.4B	Hold	27,850,460	–	–	18.91%	2
2019 Q1	$2.14B	Buy	27,850,460 +2,033,990	+8%	+$113M	100%	1
2018 Q4	$970M	Buy	+25,816,470	New	+$951M	21.29%	2

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SB Investment Advisers (UK)'s GH Position: Q2 2022 in Review

SB Investment Advisers (UK) sold out of Guardant Health (GH) in Q2 2022, closing a stake of 503,592 shares — an estimated $33.4M sold.

SB Investment Advisers (UK) first reported a position in GH in Q4 2018 and held it in 14 quarters. The position peaked at $2.4B in Q2 2019. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

SB Investment Advisers (UK) reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
SB Investment Advisers (UK) sold 503,592 Guardant Health shares in Q2 2022, an estimated $33.4M.
SB Investment Advisers (UK) first reported a position in Guardant Health in Q4 2018 and held it in 14 quarters.
SB Investment Advisers (UK)'s Guardant Health position peaked at $2.4B in Q2 2019.
332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on SB Investment Advisers (UK)'s 13F filing for Q2 2022, filed 15 Aug 2022.